Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer

Oral Oncology

Volumn 48, Issue 11, 2012, Pages 1120-1127

  Kishimoto, Koji ^a   Yoshida, Shoko ^a   Ibaragi, Soichiro ^a   Yoshioka, Norie ^a   Okui, Tatsuo ^a   Hu, Guo Fu ^b   Sasaki, Akira ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Angiogenin; Cell proliferation; Hypoxia; Hypoxia inducible factor 1 (HIF 1 ); Oral cancer; Ribosome biogenesis; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PUROMYCIN; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOGENESIS; CANCER GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, NUDE; MOUTH NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEASE, PANCREATIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867846527     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.05.009     Document Type: Article

References (31)

1. R. Hasina, and M.W. Lingen Angiogenesis in oral cancer J Dent Educ 65 11 2001 1282 1290
2. J.R. Tonra, and D.J. Hicklin Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy Immunol Invest 36 1 2007 3 23
3. L. Chen, and G.F. Hu Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma Oral Oncol 46 9 2010 648 653
4. J.W. Fett, D.J. Strydom, R.R. Lobb, E.M. Alderman, J.L. Bethune, and J.F. Riordan Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells Biochemistry 24 20 1985 5480 5486
5. R. Shapiro, S. Weremowicz, J.F. Riordan, and B.L. Vallee Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues Proc Natl Acad Sci USA 84 24 1987 8783 8787
6. R. Bicknell, and B.L. Vallee Angiogenin activates endothelial cell phospholipase C Proc Natl Acad Sci USA 85 16 1988 5961 5965
7. F. Moore, and J.F. Riordan Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells Biochemistry 29 1 1990 228 233
8. J. Moroianu, and J.F. Riordan Identification of the nucleolar targeting signal of human angiogenin Biochem Biophys Res Commun 203 3 1994 1765 1772
9. Z.P. Xu, T. Tsuji, J.F. Riordan, and G.F. Hu The nuclear function of angiogenin in endothelial cells is related to rRNA production Biochem Biophys Res Commun 294 2 2002 287 292
10. K. Kishimoto, S. Liu, T. Tsuji, K.A. Olson, and G.F. Hu Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis Oncogene 24 3 2005 445 456
11. T. Tsuji, Y. Sun, K. Kishimoto, K.A. Olson, S. Liu, and S. Hirukawa Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation Cancer Res 65 4 2005 1352 1360
12. L. Campo, H. Turley, C. Han, F. Pezzella, K.C. Gatter, and A.L. Harris Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival J Pathol 205 5 2005 585 591
13. A. Hartmann, M. Kunz, S. Kostlin, R. Gillitzer, A. Toksoy, and E.B. Brocker Hypoxia-induced up-regulation of angiogenin in human malignant melanoma Cancer Res 59 7 1999 1578 1583
14. H. Pilch, K. Schlenger, E. Steiner, P. Brockerhoff, P. Knapstein, and P. Vaupel Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts Int J Gynecol Cancer 11 2 2001 137 142
15. N. Yoshioka, L. Wang, K. Kishimoto, T. Tsuji, and G.F. Hu A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation Proc Natl Acad Sci USA 103 39 2006 14519 14524
16. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr Rev 18 1 1997 4 25
17. 2 homeostasis by hypoxia-inducible factor 1 Annu Rev Cell Dev Biol 15 1999 551 578
18. Z.J. Shang, Z.B. Li, and J.R. Li VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies Int J Oral Maxillofac Surg 35 6 2006 533 538
19. S. Nakayama, A. Sasaki, H. Mese, R.E. Alcalde, T. Tsuji, and T. Matsumura The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas Int J Cancer 93 5 2001 667 673
20. S. Ibaragi, N. Yoshioka, H. Kishikawa, J.K. Hu, P.M. Sadow, and M. Li Angiogenin-stimulated rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia Mol Cancer Res 7 3 2009 415 424
21. S. Ibaragi, N. Yoshioka, S. Li, M.G. Hu, S. Hirukawa, and P.M. Sadow Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription Clin Cancer Res 15 6 2009 1981 1988
22. E. Sasabe, Y. Tatemoto, D. Li, T. Yamamoto, and T. Osaki Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells Cancer Sci 96 7 2005 394 402
23. B. Shemirani, and D.L. Crowe Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases Oral Oncol 38 3 2002 251 257
24. K.M. Mohamed, A. Le, H. Duong, Y. Wu, Q. Zhang, and D.V. Messadi Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma Exp Mol Pathol 76 2 2004 143 152
25. K.Y. Detwiller, N.T. Fernando, N.H. Segal, S.W. Ryeom, P.A. D'Amore, and S.S. Yoon Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A Cancer Res 65 13 2005 5881 5889
26. K.A. Olson, T.C. French, B.L. Vallee, and J.W. Fett A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice Cancer Res 54 17 1994 4576 4579
27. K.A. Olson, J.W. Fett, T.C. French, M.E. Key, and B.L. Vallee Angiogenin antagonists prevent tumor growth in vivo Proc Natl Acad Sci USA 92 1995 442 446
28. K.A. Olson, H.R. Byers, M.E. Key, and J.W. Fett Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin Clin Cancer Res 7 11 2001 3598 3605
29. Y. Yuan, F. Wang, X.H. Liu, D.J. Gong, H.Z. Cheng, and S.D. Huang Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis Lung Cancer 66 1 2009 28 36
30. R.Y. Kao, J.L. Jenkins, K.A. Olson, M.E. Key, J.W. Fett, and R. Shapiro A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity Proc Natl Acad Sci USA 99 15 2002 10066 10071
31. D.A. Chan, T.L. Kawahara, P.D. Sutphin, H.Y. Chang, J.T. Chi, and A.J. Giaccia Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment Cancer Cell 15 6 2009 527 538